Detection of monoclonal gammopathies webinar
Abacus dx and Sebia are pleased to present an education webinar on the detection of monoclonal gammopathies.
Performance of immunotyping versus immunofixation for the detection of monoclonal gammopathies.
Event Details
Wednesday, 13th October
Brisbane: 4:00am
Sydney: 5:00am
Melbourne: 5:00am
Perth: 2:00am
Auckland: 7:00am
Due to the time different, please register for the webinar to ensure you can receive a link to the recording.
Speaker biography
Dr. Katie Thoren is an Assistant Attending Clinical Chemist at Memorial Sloan Kettering Cancer Center. She is the director of the Protein Immunology Laboratory and oversees routine protein electrophoresis and immunofixation testing. Her research focuses on translating new technologies and assays into the clinical laboratory, particularly in the area of multiple myeloma diagnostics.
Webinar overview
Serum immunofixation (IF) is routinely used in clinical laboratories to confirm the presence of an M-protein and determine its isotype. For laboratories looking for a more automated method for the detection of M-proteins, immunotyping (IT) by capillary electrophoresis is also FDA-approved to confirm the presence of these proteins and determine isotypes.
In this webinar, Dr. Katie Thoren will discuss a recent study comparing the performance of immunotyping and immunofixation for the detection of M-proteins. Thoren will demonstrate that reviewer training and experience are critical to the correct interpretation of IT results and that the analytical and clinical sensitivity is similar to IF for the detection of M-proteins. Thoren will present the data, review the limitations of each test, and discuss potential strategies for mitigating these limitations.
